Articles tagged with Muscle Diseases
Researchers have identified a gene, Kir2.6, underlying the rare genetic disease thyrotoxic hypokalemic periodic paralysis (TPP), which causes temporary muscle paralysis. The finding, published in the journal Cell, illustrates how investigations of rare genetic diseases can drive insights into more common ones.
Researchers at miRagen Therapeutics discovered microRNA-206 plays a crucial role in ALS progression and neuromuscular synaptic regeneration. This finding could lead to novel therapeutic interventions for neuromuscular disorders, offering hope for patients suffering from ALS and other diseases.
Researchers have discovered a new treatment that significantly improves disease symptoms in a genetic disorder, highlighting skeletal muscle as a viable target tissue. The therapy targets the muscle and reduces accumulation of toxic protein, improving motor performance and survival in mice with spinal and bulbar muscular atrophy.
The Muscular Dystrophy Association (MDA) has announced $5 million in new grants to support cutting-edge research projects tackling muscle diseases such as muscular dystrophy, ALS, and spinal muscular atrophy. Researchers at top institutions will explore groundbreaking treatments and therapies for these devastating conditions.
Researchers have discovered a new drug, Debio 025, which is as effective as current treatment options but without the risk of infection and immunosuppression. The study found that Debio 025 protects mice from muscle-wasting diseases similar to human muscular dystrophy.
Researchers at Western Australian Institute for Medical Research (WAIMR) have cured mice with a congenital myopathy disorder that causes babies to be born without normal muscle function. They achieved this by replacing missing skeletal muscle actin with heart actin, allowing the mice to live normally into old age.
A study by University of Florida researchers suggests that the nervous system may be the primary cause of severe breathing problems in children with Pompe disease, a rare genetic disorder. The discovery shifts responsibility from muscle weakness to signaling between the spinal cord and the diaphragm.
A recent study identified a rare genetic heart disorder, Danon disease, characterized by rapid clinical deterioration and early death in young patients. The study revealed that the natural course of this disease is often fatal, with significant cardiac complications and poor outcomes despite advanced treatment strategies.
Researchers found no increased risk of Guillain-Barré syndrome after HPV vaccination, but cases still warrant careful monitoring. The study analyzed data from the Vaccine Adverse Event Reporting System and reported 36 cases within six weeks of vaccination.
Research suggests FHL1 enhances transcription factor NFATc1 activity to promote muscle hypertrophy. Overexpressing FHL1 in mice and myoblasts resulted in increased strength and endurance.
A new study by Dr. Navah Ratzon found that amateur athletes are at risk of musculoskeletal problems due to the intensity and repetitive movements involved in their sport. To prevent such damage, experts advise incorporating stretching, balancing exercises, and proper rest into daily routines.
Researchers from Stanford's Bio-X program have devised a needle-thin probe to observe sarcomeres, the basic contracting engines of muscle, in live humans. This microendoscopy technique provides an alternative to painful muscle biopsy and could prove useful in understanding muscular diseases.
Scientists have identified a genetic mutation responsible for impaired fetal movement, which can lead to multiple miscarriages and birth defects. The mutation affects the acetylcholine receptor pathway, disrupting normal muscle function and fetal development.
Researchers found that faulty RNA plays a key role in the onset and progression of neurodegenerative diseases. They discovered that altering the RNA structure can mitigate toxicity, suggesting a common component between different types of human triplet repeat expansion diseases.
Researchers have discovered a key role for RNF5 in the development of Sporadic Inclusion Body Myositis (sIBM), a muscle disease affecting older men. The study provides new insights into the mechanism underlying sIBM and offers potential diagnostic markers and therapeutic targets.
A family-based study found a significant association between pesticide use, particularly herbicides and insecticides, and an increased risk of developing Parkinson's disease. The research team recruited 319 patients and over 200 relatives to analyze the relationship between pesticide exposure and Parkinson's disease development.
Researchers at UC Irvine found a single mitochondrial DNA mutation causes degenerative heart and muscle disease in mice, highlighting the importance of mitochondrial DNA in human health. The study's findings could lead to new treatments for age-related diseases affecting millions worldwide.
By inefficiently powering mouse muscles, researchers found increased metabolic rates reduced vascular disease, obesity, and cancer, with no impact on the aging process itself. This approach may provide a novel strategy to address age-related diseases without slowing down aging.
Researchers at the University of Rochester Medical Center have identified a synthetic RNA-based molecule that eliminates myotonia, a symptom of muscular dystrophy, in mice. The study restored normal muscle function by re-establishing a critical cellular mechanism that controls electrical activity in muscles.
The American Urological Association has released new guidelines on managing non-muscle invasive bladder cancer, focusing on treatment outcomes and complications. The guidelines highlight the importance of accurate clinical staging and the need for further research to improve patient outcomes.
Researchers at Baylor College of Medicine found that increased levels of CUGBP1 contribute to myotonic dystrophy type 1 by altering splicing patterns in heart and skeletal muscle. The study also reveals the involvement of another RNA-binding protein, MBNL1, in regulating gene expression.
Researchers at the University of Pittsburgh School of Medicine are conducting a worldwide study on treating myositis, a rare autoimmune disorder. The study will evaluate the effectiveness of rituximab in improving symptoms of dermatomyositis and polymyositis, with 202 participants from North America and Europe involved.
A study published in Neurology found that moderate strengthening exercises can slow the progression of ALS by 12%, maintaining function and quality of life. The research suggests individualized rehabilitation programs can help people with ALS maintain independence for longer.
Inflammatory myopathies and coeliac disease may be linked, with a gluten-free diet potentially improving inclusion-body myositis symptoms. Researchers explore immunopathogenic mechanisms and genetic substrates to confirm findings.
Researchers have found a way to protect muscle from degenerating after injury and improve muscle healing in mice by blocking the central signal molecule NF-kB. The study suggests two molecules with potential as promising drug targets for new therapies against muscle wasting.
Researchers found that imatinib can block the development of disease in a mouse model of rheumatoid arthritis, providing hope for a new treatment. Additionally, studying adrenomedullin's effect on female mice revealed that reduced expression may severely decrease fertility. Meanwhile, a study on TNF-alpha discovered that it decreases e...
U of MN researchers developed a mouse model for centronuclear myopathy, a poorly understood muscle disease. They found that knocking out the gamma actin gene impaired muscle cell function, leading to muscle cell death, and identified this protein as a key player in muscle structure.
Researchers used gene therapy to eliminate disabling muscle contractions in a mouse model of the most common form of adult-onset muscular dystrophy. The approach corrected myotonia, or muscle hyperexcitability, and eliminated muscle contractions as early as four weeks after injection.
Two new research centers will explore new treatment strategies and biochemical pathways contributing to muscular dystrophy. Clinical trials and laboratory studies will focus on increasing muscle growth, inhibiting enzyme breakdown, and identifying genetic modifiers.
A newly discovered muscle gene, Srpk3, has been linked to centronuclear myopathy, a rare genetic disorder affecting skeletal muscles. Researchers found that mice lacking the gene exhibit symptoms similar to those seen in humans with centronuclear myopathy, suggesting potential human mutations exist.
A researcher created a model to simulate the dynamics of heart rhythm disorders, including ventricular tachycardia and fibrillation. The model revealed that only six spiral waves are present in the heart during fibrillation, contradicting previous assumptions about its chaotic nature.
A study analyzing claims data from 11 managed care health plans found that the risk of rhabdomyolysis is relatively low with three frequently prescribed statins. The study suggests that patients taking statins and fibrates combined, such as those with diabetes mellitus, should be monitored for symptoms suggestive of rhabdomyolysis.
Scientists uncover vital role of Periaxin gene in causing CMT, a disabling disease affecting 23,000 people in the UK. The new research provides insight into how nerves work and may lead to development of gene therapies to correct faulty genes.
University of Alberta researchers provide independent verification that CFS patients are distinct from those with depression. The study used electrodermal activity to demonstrate differences in skin temperatures and electrodermal activity between CFS and depression patients.
Researchers have discovered that a gene therapy using growth factor VEGF can slow down the onset and progression of ALS in mice, increasing life expectancy by 30%. This treatment has shown promising results without toxic side effects, offering new hope for patients with this incurable disease.
Researchers at UT Southwestern Medical Center discovered a master regulator of smooth muscle development, protein myocardin, which controls growth and differentiation. This finding offers new insights into the cellular mechanisms controlling smooth muscle cell proliferation, potentially leading to novel therapeutics for cardiovascular ...
Researchers at UT Southwestern have discovered an effective treatment for McArdle's disease, a rare muscle disorder characterized by fatigue and cramping during exercise. The treatment involves administering an oral source of glucose to improve exercise tolerance in patients with the condition.
A study at TSRI identifies 62 new proteins in the inner nuclear membrane linked to 14 rare diseases, including muscular dystrophy and Charcot-Marie-Tooth disease. This discovery has significant implications for understanding the underlying causes of these devastating conditions and developing new therapeutic strategies.
Researchers discovered a gene mutation associated with a form of Charcot-Marie-Tooth disease, affecting approximately 1 in 2,000 people. The LITAF gene mutation was found in families with a history of the disease, suggesting its potential as a molecular marker for diagnosis.
Researchers at Vanderbilt University Medical Center have developed a novel gene therapy approach that repairs messenger RNA, which could lead to effective treatments for inherited diseases. The method uses ribozymes to correct defective genes and has shown promising results in animal models.
Researchers found that abnormally short DNA sequences on chromosome 4 interfere with the function of a protein complex, leading to over-activity of nearby genes. This discovery provides insights into novel ways genes can influence disease and may lead to new treatments for FSHD.
A novel cardiac glycogen storage disease has been identified through research published in the Journal of Clinical Investigation. The study sheds new light on the genetic causes and consequences of this rare condition, offering potential avenues for improved diagnosis and therapy.
Researchers at USC have discovered an increase in BACE enzymes in patients with inclusion-body myositis (IBM), a crippling muscle disease. The findings suggest that cholesterol may play a role in the production of toxic amyloid-ß protein, which could lead to new treatment options for both IBM and Alzheimer's disease.
Researchers from Israel and abroad identified the genetic mutation causing Hereditary Inclusion Body Myopathy (HIBM), a degenerative muscle disease affecting Jews of Persian descent. The mutations affect an enzyme crucial for protein synthesis, leading to muscle degeneration.
A new therapy effectively treats a disease similar to multiple sclerosis in monkeys by targeting T cells that cause the disease. The approach could soon be tested against MS and other autoimmune diseases in humans, offering potential for improved treatment options.
A recent study suggests that methionine, a chemical found in beta-amyloid protein, may play a role in slowing the progression of Alzheimer's disease. Vitamin E's antioxidant properties appear to destroy free radicals produced by amyloid, providing a possible explanation for its link to slowing the disease.
Researchers discovered a modified antioxidant enzyme that delayed onset and increased survival of mice with familial amyotrophic lateral sclerosis (ALS or Lou Gehrig's disease). The study found that the polyamine-modified catalase better penetrated the blood-brain barrier, reducing levels of hydrogen peroxide and nitric oxide.
A study by the American Heart Association found that individuals with heart attacks are more likely to have periodontal disease, a type of gum tissue inflammation. The researchers believe that high blood levels of C-reactive protein may be linked between the two conditions.
Researchers found that up to 96% of Parkinson's patients experience serious sleep disturbances, often overlooked by doctors. A new study suggests that cabergoline, a long-acting dopamine agonist, offers significant benefits in improving symptoms of sleep disturbance and daytime sleepiness.
A new study published in JAMA found that initiating therapy with MIRAPEX delayed the onset of motor complications and reduced their incidence compared to patients on initial treatment with levodopa. At two years, 72% of MIRAPEX-treated patients were free from motor complications.
Researchers found that pramipexole, a dopamine agonist, reduces debilitating complications in Parkinson's patients. However, it may not control disease symptoms as well as levodopa, which carries more side effects.
Italian researchers found that workers exposed to hydrocarbon solvents, such as petroleum-based products, were three years younger when first showing symptoms. The severity of Parkinson's disease was directly related to the amount of exposure experienced.
Researchers analyzed biologic, chemical, and genetic mechanisms to understand how SCA2 gene mutations cause damaged nerve cells. They found basic mechanisms in SCA2 cells differ from other genes associated with neurodegenerative diseases, suggesting new treatment possibilities for ataxia and related conditions.
Researchers found that adults with sufficient calcium consumption have significantly lower rates of periodontal disease. The study suggests that calcium plays a crucial role in building density in the alveolar bone that supports the teeth, helping to prevent bacterial onslaughts that can lead to infection and tooth loss.
Researchers discovered a new gene, neurofilament light, associated with Charcot-Marie-Tooth disease, which affects peripheral nerves and leads to progressive weakness. The defect is linked to demyelination, resulting in axonal loss and muscle denervation, also seen in other neurological disorders like Parkinson's and Alzheimer's diseases.
Researchers found that people exposed to pesticides were approximately two times more likely to develop Parkinson's disease than those not exposed. In-home exposure to insecticides carried the highest risk of developing the disease.
A research team at the Max Planck Institute of Neurobiology has discovered a new genetic cause for muscular dystrophy, uncovering a subtle disturbance in muscle fibre architecture. This breakthrough could improve diagnosis and therapeutic strategies for degenerative muscle disorders.
Scientists have pinpointed abnormalities in gene expression that occur before signs of spinocerebellar ataxia type 1 (SCA1) appear. Researchers found six genes whose expression pattern is altered by the abnormal SCA1 gene, including a gene involved in regulating calcium levels in neurons.
Researchers at the UK College of Medicine are developing a technology to deliver drugs directly into brain tissue to treat Parkinson's disease. The team plans to use a modified Medtronic pump to deliver GDNF, a protein that has shown promise in protecting dopaminergic neurons in preclinical studies.
Researchers have successfully reversed damage caused by Pompe disease, a rare inherited muscle-wasting disorder, in laboratory mice using a modified virus to deliver a therapeutic gene. The study's findings show promise for treating dozens of forms of muscular dystrophy and may lead to a continuous supply of enzyme production.